Clinical Trials Directory

Trials / Completed

CompletedNCT01002677

Behavioral Trial Studying Programmed Training to Improve Advocacy Skills for Individuals With Traumatic Brain Injury

Midwest Advocacy Project: A Community-based Randomized Practical Behavioral Trial of Programmed Advocacy Training for Individuals With Traumatic Brain Injury and Their Significant Others

Status
Completed
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
234 (actual)
Sponsor
Mayo Clinic · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The Midwest Advocacy Project (MAP) is a community-based multiple-site randomized practical behavioral trial of advocacy skill training for individuals with traumatic brain injury (TBI), their families, and significant others. The purpose is to evaluate the efficacy of a 4-session advocacy training program to improve behavioral advocacy skills compared to self-directed advocacy training of the same session frequency. Groups will be randomly assigned to either a programmed group or a self-directed group in collaboration with the Brain Injury Associations of Minnesota, Iowa, and Wisconsin each year over the 5 year study period. The primary outcome is pre-post measures of written and verbal advocacy skill measured by the Advocacy Behavior Rating Scale. It is hypothesized that subjects who receive programmed advocacy training will show greater positive change on pre-post measures of advocacy skill measures than subjects receiving self-directed training.

Conditions

Interventions

TypeNameDescription
BEHAVIORALAdvocacy training curriculumDay-long presentation of an advocacy training curriculum by the state's Brain Injury Association staff: One session per month for 4 consecutive months.
BEHAVIORALSelf-directedDay-long group-based self-directed advocacy training activity: One session per month for 4 consecutive months.

Timeline

Start date
2007-08-01
Primary completion
2012-09-01
Completion
2012-09-01
First posted
2009-10-27
Last updated
2013-01-17

Locations

3 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01002677. Inclusion in this directory is not an endorsement.